AC
OKUR

Aldebaran Capital’s OnKure Therapeutics OKUR Stock Holding History

Aldebaran Capital’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Sell
39,869
-550
-1% -$2.36K 0.14% 38
2026
Q1 		$167K Sell
40,419
-865
-2% -$2.67K 0.13% 42
2025
Q4 		$120K Sell
41,284
-2,713
-6% -$8.12K 0.11% 35
2025
Q3 		$121K Sell
43,997
-176
-0.4% -$436 0.11% 33
2025
Q2 		$106K Sell
44,173
-875
-2% -$2.29K 0.1% 34
2025
Q1 		$194K Sell
45,048
-524
-1% -$2.95K 0.18% 39
2024
Q4 		$392K Buy
45,572
+360
+0.8% +$5.45K 0.37% 31
2024
Q3 		$769K Buy
45,212
+450
+1% +$6.66K 0.7% 25
2024
Q2 		$676K Buy
44,762
+5,121
+13% +$86.8K 0.63% 24
2024
Q1 		$658K Buy
+39,641
New +$654K 0.63% 23

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aldebaran Capital's OKUR Position: Q2 2026 in Review

Aldebaran Capital reduced its OnKure Therapeutics (OKUR) stake by 1.4% in Q2 2026, selling an estimated $2.36K and leaving 39,869 shares worth $182K. The position accounts for 0.14% of the portfolio, ranked #38.

Aldebaran Capital first reported a position in OKUR in Q1 2024 and has held it in 10 quarters since. The position peaked at $769K in Q3 2024. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Aldebaran Capital held 39,869 shares of OnKure Therapeutics worth $182K as of Q2 2026.
  • Aldebaran Capital sold 550 OnKure Therapeutics shares in Q2 2026, an estimated $2.36K.
  • OnKure Therapeutics made up 0.14% of Aldebaran Capital's portfolio in Q2 2026, its #38 holding.
  • Aldebaran Capital first reported a position in OnKure Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Aldebaran Capital's OnKure Therapeutics position peaked at $769K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Aldebaran Capital's 13F filing for Q2 2026, filed 14 Aug 2026.